Vantage Investment Partners, LLC Johnson & Johnson Transaction History

Vantage Investment Partners, LLC

$1.19 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 24, 2023	SELL	$154.35 - $166.11 $2.53 Million - $2.72 Million	-16,360 Reduced 24.84%	49,492 $8.19 Million
Q1 2023 Apr 18, 2023	BUY	$151.05 - $180.26 $1 Million - $1.2 Million	6,653 Added 11.24%	65,852 $10.2 Million
Q4 2022 Jan 27, 2023	BUY	$160.2 - $179.79 $397,936 - $446,598	2,484 Added 4.38%	59,199 $10.5 Million
Q3 2022 Oct 18, 2022	BUY	$161.33 - $179.52 $48,399 - $53,856	300 Added 0.53%	56,715 $9.27 Million
Q2 2022 Jul 28, 2022	BUY	$168.19 - $186.01 $117,733 - $130,207	700 Added 1.26%	56,415 $10 Million
Q1 2022 Apr 22, 2022	SELL	$158.14 - $179.59 $365,461 - $415,032	-2,311 Reduced 3.98%	55,715 $9.87 Million
Q4 2021 Jan 21, 2022	BUY	$155.93 - $173.01 $1.87 Million - $2.07 Million	11,989 Added 26.04%	58,026 $9.93 Million
Q3 2021 Oct 13, 2021	SELL	$161.5 - $179.47 $2.62 Million - $2.91 Million	-16,230 Reduced 26.07%	46,037 $7.44 Million
Q2 2021 Jul 29, 2021	BUY	$159.48 - $171.07 $937,901 - $1.01 Million	5,881 Added 10.43%	62,267 $10.3 Million
Q1 2021 May 03, 2021	BUY	$153.07 - $170.48 $655,445 - $729,995	4,282 Added 8.22%	56,386 $9.27 Million
Q4 2020 Jan 25, 2021	SELL	$137.11 - $157.38 $2.03 Million - $2.33 Million	-14,780 Reduced 22.1%	52,104 $8.2 Million
Q3 2020 Oct 22, 2020	BUY	$140.38 - $153.83 $202,147 - $221,515	1,440 Added 2.2%	66,884 $9.96 Million
Q2 2020 Jul 21, 2020	BUY	$128.81 - $155.51 $485,613 - $586,272	3,770 Added 6.11%	65,444 $9.2 Million
Q1 2020 Apr 28, 2020	BUY	$111.14 - $153.99 $406,327 - $562,987	3,656 Added 6.3%	61,674 $8.09 Million
Q4 2019 Feb 10, 2020	BUY	$127.5 - $146.44 $14,917 - $17,133	117 Added 0.2%	58,018 $8.46 Million
Q3 2019 Oct 24, 2019	BUY	$126.95 - $142.14 $2,412 - $2,700	19 Added 0.03%	57,901 $7.49 Million
Q2 2019 Aug 07, 2019	SELL	$131.15 - $144.24 $1.5 Million - $1.65 Million	-11,431 Reduced 16.49%	57,882 $8.06 Million
Q1 2019 May 10, 2019	BUY	$125.72 - $139.79 $28,287 - $31,452	225 Added 0.33%	69,313 $9.69 Million
Q4 2018 Feb 06, 2019	SELL	$122.84 - $147.84 $61,051 - $73,476	-497 Reduced 0.71%	69,088 $8.92 Million
Q3 2018 Oct 31, 2018	SELL	$121.58 - $142.88 $245,834 - $288,903	-2,022 Reduced 2.82%	69,585 $9.61 Million
Q2 2018 Aug 01, 2018	SELL	$119.4 - $131.76 $1.68 Million - $1.85 Million	-14,034 Reduced 16.39%	71,607 $8.69 Million
Q1 2018 May 14, 2018	BUY	$125.1 - $148.14 $1,000 - $1,185	8 Added 0.01%	85,641 $11 Million
Q4 2017 Feb 15, 2018	BUY	$131.22 - $143.62 $10.1 Million - $11.1 Million	77,070 Added 900.04%	85,633 $12 Million
Q4 2017 Feb 14, 2018	SELL	$131.22 - $143.62 $12.3 Million - $13.5 Million	-93,789 Reduced 91.63%	8,563 $1.2 Million
Q3 2017 Nov 14, 2017	SELL	$129.47 - $135.38 $479,556 - $501,447	-3,704 Reduced 3.49%	102,352 $13.3 Million
Q2 2017 Aug 14, 2017	BUY	N/A	106,056	106,056 $14 Million

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $405B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vantage Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vantage Investment Partners, LLC with notifications on news.

Account